info@allievapharma.com


  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company

Product Details

Fosaprepitant Dimeglumine for Injection 150mg

Fosaprepitant Dimeglumine for Injection 150mg


Brand NameAPRELIEVA 150MG
CompositionFosaaprepitant Dimeglumine for Injection 150mg
Manufacture ByAllieva Pharma Private Limited
FormInjection
PackingVial
Country Of OriginIndia

Description

Description

APRELIEVA 150 mg contains Fosaprepitant Dimeglumine, a neurokinin-1 (NK1) receptor antagonist. It is a prodrug of aprepitant and works by blocking substance P in the brain, thereby preventing chemotherapy-induced nausea and vomiting (CINV), especially delayed emesis.

Uses

Fosaprepitant is used for prevention of:

1. Chemotherapy-Induced Nausea and Vomiting (CINV)
    – Associated with highly emetogenic chemotherapy (HEC)
    – Associated with moderately emetogenic chemotherapy (MEC)

It is used in combination with:

•  A 5-HT3 receptor antagonist (e.g., ondansetron)

•  Dexamethasone

Side Effects

Common side effects:

•  Fatigue

•  Hiccups

•  Headache

•  Constipation or diarrhea

Injection-site reactions:

•  Pain

•  Erythema

•  Phlebitis

Serious side effects (rare):

•  Hypersensitivity reactions

•  Anaphylaxis

Monitor for infusion-site reactions.

Dosage

Standard adult dose:

•  150 mg IV single dose

•  Administered 30 minutes before chemotherapy on Day 1

 Replaces 3-day oral aprepitant regimen.

NOTE: This medicine should be taken only under a doctor’s supervision.


24/7 Clients Support

Best Price

Quality Assurance
function changeImage(elem, src) { document.getElementById("mainImage").src = src; document.querySelectorAll(".thumbnail-container img").forEach(img => img.style.border = "2px solid transparent"); elem.style.border = "2px solid #007bff"; }